These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33839225)
1. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy. Ren T; Zheng X; Bai R; Yang Y; Jian L Int J Pharm; 2021 May; 601():120583. PubMed ID: 33839225 [TBL] [Abstract][Full Text] [Related]
2. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel. Ren T; Gou J; Sun W; Tao X; Tan X; Wang P; Zhang Y; He H; Yin T; Tang X Mol Pharm; 2018 Jul; 15(7):2870-2882. PubMed ID: 29863879 [TBL] [Abstract][Full Text] [Related]
3. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System. Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption. Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014 [TBL] [Abstract][Full Text] [Related]
5. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles. Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432 [TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease. Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
8. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
9. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice. Bao X; Qian K; Yao P J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323 [TBL] [Abstract][Full Text] [Related]
10. Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice. Shi Y; Sun X; Zhang L; Sun K; Li K; Li Y; Zhang Q Sci Rep; 2018 Jan; 8(1):726. PubMed ID: 29335533 [TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4. Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281 [TBL] [Abstract][Full Text] [Related]
13. Improved oral delivery of insulin by PLGA nanoparticles coated with 5 Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498 [TBL] [Abstract][Full Text] [Related]
14. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850 [TBL] [Abstract][Full Text] [Related]
15. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery. Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421 [TBL] [Abstract][Full Text] [Related]
16. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
17. zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery. Liu K; Chen Y; Yang Z; Jin J Int J Biol Macromol; 2023 May; 236():123870. PubMed ID: 36870645 [TBL] [Abstract][Full Text] [Related]
18. Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: Design, optimization and evaluation. Wang F; Shan Q; Chang X; Li Z; Gui S Int J Pharm; 2021 Jun; 602():120617. PubMed ID: 33887394 [TBL] [Abstract][Full Text] [Related]
19. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin. Hussein AS; Abdullah N; Ahmadun FR IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903 [TBL] [Abstract][Full Text] [Related]
20. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]